Erector Spina Plane Block in Laparoscopic Sleeve Gastrectomy Surgery

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 1, 2019

Primary Completion Date

December 4, 2019

Study Completion Date

December 4, 2019

Conditions
Obesity
Interventions
DRUG

ESPB group

USG probe will be placed in a longitudinal parasagittal orientation 3 cm lateral to T7 spinous process. The erector spinae muscles will be identified hyperechoic transverse process. The patient's skin will be anesthetized with 2% lidocaine. A 21-gauge 10-cm needle was inserted using an in-plane superior-to-inferior approach or an outplane approach. Following confirmation of the correct position of the needle with 5 ml normal saline, a dose of 20 ml %0.25 bupivacaine will be administered. The same procedure will be performed at the other site (totally 40 ml %0.25 bupivacaine). Standard pain follow up and monitorization will be performed.

DRUG

Control group

The patients in this group will be performed no block. Standard pain follow up and monitorization will be performed.

Trial Locations (1)

07100

Antalya Training and Research Hospital, Department of Anesthesiology and Reanimation, Antalya

All Listed Sponsors
lead

Antalya Training and Research Hospital

OTHER_GOV

NCT04039321 - Erector Spina Plane Block in Laparoscopic Sleeve Gastrectomy Surgery | Biotech Hunter | Biotech Hunter